Global X Genomics & Biotechnology ETF
GNOM
60 hedge funds and large institutions have $18.7M invested in Global X Genomics & Biotechnology ETF in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 10 closing their positions.
88% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 16
8.2% less ownership
Funds ownership: 44.53% → 36.33% (-8.2%)
14% less funds holding
Funds holding: 70 → 60 (-10)
80% less capital inflows, than outflows
Capital inflows: $1.82M | Capital outflows: $8.86M
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $37K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$264K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$212K |
| 3 |
Oppenheimer Asset Management
New York
|
+$207K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$188K |
| 5 |
Flow Traders U.S.
New York
|
+$135K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
One Capital Management
Westlake Village,
California
|
-$3.22M |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
-$2.55M |
| 3 |
Krilogy Financial
St. Louis,
Missouri
|
-$922K |
| 4 |
CA
Corrado Advisors
Ramsey,
New Jersey
|
-$731K |
| 5 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
-$417K |
GNOM Hedge Fund Activity: Q1 2025 in Review
60 of the 7,478 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q1 2025, worth a combined $18.7M — down 38% from $30.1M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of GNOM and 2 opened new positions — a net loss of 8 holders — while 16 trimmed existing stakes and 30 added.
The largest buyer was LPL Financial, adding an estimated $264K. The largest seller was One Capital Management, cutting an estimated $3.22M.
- 60 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q1 2025, down from 70 in Q4 2024.
- Funds reported $18.7M of Global X Genomics & Biotechnology ETF stock for Q1 2025, down 38% quarter-over-quarter.
- 2 funds opened new Global X Genomics & Biotechnology ETF positions in Q1 2025 and 10 closed out, a net change of -8 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q1 2025 was LPL Financial, an estimated $264K added.
- The largest Global X Genomics & Biotechnology ETF seller in Q1 2025 was One Capital Management, an estimated $3.22M sold.
Based on aggregated 13F filings for Q1 2025.